1. Stocks G. Abuse of propofol by anesthesia providers: the case for re-classification as a controlled substance. J Addict Nurs. 2011; 22:57–62.
Article
2. Park JH, Kim HJ, Seo JS. Medicolegal review of deaths related to propofol administration: analysis of 36 autopsied cases. Korean J Leg Med. 2012; 36:56–62.
Article
3. Lee S, Lee MS, Kim YA, Ahn WS, Lee HC. Propofol abuse of the medical personnel in operation room in Korea. Korean J Leg Med. 2010; 34:101–107.
5. Jung YJ. The number of doctors arrested for drug-related offences increased by 64%. The Munwha Ilbo. 2012. 08. 14.
6. Park SS. Medical environment and drug abuse among physicians: current state and problems in Korea. J Korean Med Assoc. 2013; 56:755–761.
Article
7. Wise RA, Bozarth MA. Action of drugs of abuse on brain reward systems: an update with specific attention to opiates. Pharmacol Biochem Behav. 1982; 17:239–243.
Article
8. Kalivas PW. Cocaine and amphetamine-like psychostimulants: neurocircuitry and glutamate neuroplasticity. Dialogues Clin Neurosci. 2007; 9:389–397.
Article
9. Roussin A, Montastruc JL, Lapeyre-Mestre M. Pharmacological and clinical evidences on the potential for abuse and dependence of propofol: a review of the literature. Fundam Clin Pharmacol. 2007; 21:459–466.
Article
10. Hong SH. Propofol abuse among healthcare professionals. J Korean Med Assoc. 2013; 56:771–777.
Article
11. Moon YE. Treating and preventing relapse of drug abuse by healthcare providers. J Korean Med Assoc. 2013; 56:778–783.
Article
12. Gallegos KV, Lubin BH, Bowers C, Blevins JW, Talbott GD, Wilson PO. Relapse and recovery: five to ten year follow-up study of chemically dependent physicians: the Georgia experience. Md Med J. 1992; 41:315–319.